Key statistics dashboard for Simulations Plus, Inc. (SLP). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus, Cognigen, DILIsym, and Lixoft.
Stock Data
| Price | $18.43 |
| Market Cap | $373M |
| Beta | 1.19 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 44.92 |
| Price / Book | 2.67 |
| P/S | 4.54 |
| P/FCF | 14.28 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 63.38% |
| EBIT Margin | 14.30% |
| EBITDA Margin | 15.95% |
| Operating Margin | 14.02% |
| Net Margin | 9.88% |
Financial Health
| Current Ratio | 5.54 |
| Quick Ratio | 5.54 |
| Cash Ratio | 2.60 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.32% |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 4.07 |
| Book Value per share | 6.89 |
| Cash per share | 2.48 |
| FCF per share | 1.29 |
| Tangible Book Value per share | 3.91 |
| Dividend per share | 0.00 |
Related companies: ACIU · AGL · ANRO · CLLS · DH · KRRO · NAKA
Explore sector: Technology · Software - Application
More sections of SLP: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks